Background
==========

The delta smelt (*Hypomesus transpacificus*) is a pelagic fish species endemic to the Sacramento-San Joaquin estuary, whose abundance has dramatically declined since the 1980s, and more precipitously in recent years \[[@B1]-[@B4]\]. It was listed as endangered in 2009, under both the Federal Endangered Species Act (ESA) and California Endangered Species Act (CESA). Considerable efforts are presently being made to understand the causes of this recent population decline \[[@B4],[@B5]\], especially because several other pelagic species have shown similar population trends. Delta habitats have been compromised by a number of complex factors, both known and unknown, potentially affecting aquatic species throughout the Sacramento-San Joaquin watersheds and estuary \[[@B4]\]. Pollution, in the form of chemicals contained in runoff from agricultural and urban areas, and old mining sites, treated wastewater effluent, along with the effects of water exports, invasive species and habitat destruction are amongst potential causes for the population decline of several pelagic species \[[@B5]\].

Identifying the sublethal impacts of environmental stressors and their mechanistic effects on resident individuals and populations is a major challenge in ecotoxicology. Contaminants may not only affect organism survival, but can compromise ecological fitness of individual species via sublethal physiological, behavioral or immunological effects (e.g. \[[@B6]-[@B10]\]), consequently altering food web and ecosystem dynamics. However, such physiological endpoints are often difficult to determine in field studies, because they either require behavioral observation and measurements, or because affected individuals will not survive in the wild. Similarly, widely used ecotoxicological tools such as standard toxicity tests \[[@B11],[@B12]\] cannot easily be adapted to resident species of concern, and, conversely, it is problematic to extrapolate test results obtained with surrogate species to resident species of concern \[[@B13]\]. Recent comparative studies have demonstrated a need for identifying effects directly in the species of concern, as traditional model organisms may differ in sensitivity and physiological response to environmental contaminants and other stressors \[[@B14],[@B15]\].

Carefully selected molecular biomarkers can provide species-specific and sensitive, mechanistic information on the overall health of an organism, as toxic responses are often preceded by alterations in gene expression \[[@B16],[@B17]\]. In particular microarray gene profiling is a powerful tool for defining genome-wide effects of environmental change on biological function \[[@B16],[@B18],[@B19]\]. The predictive value of microarrays as screening tools, as well as our understanding of these responses and their application in the field of ecotoxicology is rapidly growing. This technology can be applied in vertebrates and invertebrates, plants, algae, cell lines and unicellular organisms \[[@B20]\]. In addition, links are being established between specific molecular biomarkers identified by microarray technology, and higher-level life history parameters, such as metabolism, growth and reproduction \[[@B16],[@B18],[@B21],[@B22]\]. Gene expression studies carried out over short-term exposures have allowed for the prediction of chronic stressor effects, such as reduced fecundity and embryonic arrest, somatic growth, and population dynamics \[[@B16],[@B18],[@B21],[@B23]\]. Thus, specific gene responses in studied organisms would not only be indicative of health status, but when used in conservation studies, could highlight potential causes for population decline. However, few biomarkers are currently understood well enough to provide conclusive evidence of contaminant impacts on aquatic species in field monitoring, and extrapolating effects seen at the biomarker level to individual or population-level toxicity continues to be a challenge. For molecular biomarkers to be used as successful monitoring tools of individual, population and ecosystem damage, strong links need to continue to be established between gene expression and health status.

To better understand the sublethal effects of contaminants upon *H. transpacificus*, and to identify biomarkers for future field investigations, we have constructed a microarray with 8,448 Expressed Sequence Tags (ESTs). No genomic information was available on any database at the time this project began, other than a few mitochondrial sequences used in taxonomic studies \[[@B24]\]. We describe here, the construction and first application of this tool to identify genes in the delta smelt, specifically responding to exposure to esfenvalerate, a pyrethroid insecticide, and present gene expression quantitation of selected biomarkers, utilizing these to explain observed swimming abnormalities. We used esfenvalerate in our study because biochemical responses and adverse effects on the whole organisms are relatively well understood \[[@B25]\] and therefore would aid interpretation of results in this \"proof of principle\" test. Esfenvalerate \[(*S*)-a-cyano-3-phenoxybenzyl-(*S*)-2-(-4-chlorophenyl)-3-methylbutyrate\] is a synthetic pyrethroid insecticide, widely used in agriculture, with a high risk to aquatic organisms \[[@B26]\]. It causes neurological damage by blocking sodium and potassium channels, resulting in repetitive neurological discharge \[[@B25]\]. In addition, pyrethroid insecticides are highly soluble in myelin sheaths of nerves, causing demyelination, resulting in conduction deficiencies through nerve lesions \[[@B27]\], directly affecting swimming ability, and impinging on foraging and migration. Fish are highly sensitive to this insecticide, with for example effects on bluegill behavior at measured concentrations as low as 0.025 μg/L^-1^\[[@B28]\]. Pyrethroids have also been reported to affect growth, induce immune responses, reduce hepatic glycogen levels and delay spawning \[[@B9],[@B29]\].

The main focus of this study was not the development of the microarray, rather the identification of molecular biomarkers specific to the delta smelt and stressors found in the San Joaquin-Sacramento delta. We present here results from annotated genes identified through microarray analyses and specifically quantitative PCR analyses of selected molecular biomarkers.

Results and Discussion
======================

Effects of esfenvalerate exposure: mortality and swimming behavior
------------------------------------------------------------------

Fish larvae are known to be highly sensitive to esfenvalerate, with effects on swimming performance and enhanced susceptibility to predation resulting from concentrations as low as 0.0625 μg/L^-1^\[[@B10]\]. Behavior alterations are construed as being consequential to the reported neurological mode of action of this pesticide, further affecting foraging, migration and reproduction \[[@B30]\]. Toxicity of pyrethroids in the Sacramento-San Joaquin estuary is likely alleviated by the presence of particles and organic matter, and to date concentrations of esfenvalerate detected in the water column were low, however, concentrations in winter storm runoff from agricultural lands have been reported up to 0.093 μg.L^-1^\[[@B31]\], influencing our decision to investigate dose response exposures to both high and environmentally relevant concentrations in confirmatory studies.

In terms of mortality, 10-d old delta smelt were only slightly more sensitive in this study (LC~50,24\ h~= 0.19 μg.L^-1^) than 52-d old (LC~50,24\ h~= 0.24 μg.L^-1^), however swimming performance of the younger larvae was affected at a concentration approximating one third of that observed affecting older fish (figure [1](#F1){ref-type="fig"}). Swimming abnormality in 10-d old larvae, intensified with increasing esfenvalerate concentration at 4 h, escalating significantly after 24 h exposure (figure [1a](#F1){ref-type="fig"}). This swimming abnormality was also concentration dependent in 52-d old fish, however swimming effects resulting from different time point measurements differed only at the highest exposure concentration of 0.250 μg.L^-1^(figure [1b](#F1){ref-type="fig"}), where effects on motion increased from 22.5% anomaly at 4 h to 45% at 24 h. Behavioral abnormalities, reduced food intake and growth, as well as increased susceptibility to predation were reported in fathead minnow larvae exposed to esfenvalerate for 4 h to concentrations above 0.455 μg.L^-1^\[[@B10]\]. Significant swimming impairments were determined in this study at 0.250 μg.L^-1^, thus delta smelt are highly sensitive to sublethal esfenvalerate exposure. Furthermore, bioaccumulation in rainbow trout have resulted in concentrations 400 times higher than background ambient levels <http://extoxnet.orst.edu>.

![**Swimming behavior and mortality**. Percentage swimming normality and survival in (a.) 10-d old and (b.) 52-d old *H. transpacificus*exposed to esfenvalerate, ± standard errors (n = 10). \* Indicates significant reduction in survival or swimming performance compared to solvent control.](1471-2164-10-608-1){#F1}

Microarray application and q-PCR
--------------------------------

Through the application of the delta smelt microarrays, and combined analytical methods, we have identified 288 ESTs, from which a number of genes of interest could be used to measure the effect of esfenvalerate and potentially other pyrethroid insecticides; further investigating their use as biomarkers in this species. Of the sequenced ESTs that responded significantly, 118 genes were successfully annotated; 170 matched unnamed or hypothetical proteins, or did not match the described annotation selection criteria; i.e. BLASTx searches resulted in expect-values greater than 1 × 10^-5^and scores below 50. Based on gene ontology; molecular function, biological processes and cellular components, 94 unique genes were functionally classified (figure [2](#F2){ref-type="fig"} and table [1](#T1){ref-type="table"}) and described below. Based on the proportions of ESTs responding to successfully annotated unique genes (33%), it is estimated that of the 8,448 ESTs printed on the microarray, there could be above 2,500 unique genes identified in the delta smelt. These numbers however represent responses to a single contaminant, and should not be construed as final as there will have an intrinsic bias exerted upon them, however, the proportion of repeated sequences in the analyses was very low, with a maximum of nine repetitions for CHK1 checkpoint homologue and not more than one or two duplication for a few others. It is also important to note that the microarray was manufactured with incomplete genome data, thus information presented in figure [2](#F2){ref-type="fig"} represents proportions of a limited number of available genes.

###### 

Classification of differential gene expression of esfenvalerate responding genes in 52-d old *H. transpacificus*following 24 h exposure as identified by microarray analyses.

  BLASTX top hit                                                Species match              Accession No.                  Score   E-value    Concentration   Fold Change (+/-)   P-VALUE (or cut-off)   
  ------------------------------------------------------------- -------------------------- ------------------------------ ------- ---------- --------------- ------------------- ---------------------- ------
  [Neuromuscular]{.ul}                                                                                                                                                                                  
  **titin a**                                                   *Danio rerio*              [ABG48500](ABG48500)           110     4.00E-23   0.0625          1.3277              0.0625                 \*\*
  smooth muscle cell-specific protein SM22 alpha                *Epinephelus coioides*     [ABW04145](ABW04145)           349     1.00E-94   0.1250          1.2252              0.0029                 
  toxin-1                                                       *Oncorhynchus mykiss*      [AAM21198](AAM21198)           116     5.00E-25   0.1250          1.1884              0.0044                 
  thymosin beta-12                                              *Lateolabrax japonicus*    [P33248](P33248)               80      2.00E-13   0.1250          1.1876              0.0003                 
  similar to 19.9 kD myosin light chain isoform 1               *Danio rerio*              [XP_685183](XP_685183)         332     1.00E-89   0.1250          1.1720              0.0046                 
  ictacalcin                                                    *Ictalurus punctatus*      [AAY86967](AAY86967)           145     1.00E-33   0.1250          1.1607              0.0021                 
  tropomyosin                                                   *Theragra chalcogramma*    [BAC44994](BAC44994)           281     2.00E-74   0.1250          1.1368              0.0090                 
  N-acylsphingosine amidohydrolase                              *Takifugu rubripes*        [AAM43813](AAM43813)           367     e-100      0.1250          1.1196              0.0082                 
  alanine-glyoxylate aminotransferase                           *Platichthys flesus*       [CAH59400](CAH59400)           345     2.00E-93   0.1250          1.0860              0.0059                 
  titin b                                                       *Danio rerio*              [ABG48499](ABG48499)           65      5.00E-09   0.1250          -1.0841             0.0045                 
  alpha-2,8-polysialyltransferase IV                            *Oncorhynchus mykiss*      [BAC77411](BAC77411)           70      1.00E-10   0.1250          -1.0878             0.0030                 
  hedgehog acyltransferase-like, a                              *Danio rerio*              [NP_957181](NP_957181)         295     1.00E-78   0.1250          -1.1419             0.0074                 
  **parvalbumin**                                               *Cyprinus carpio*          [CAC83659](CAC83659)           173     7.00E-42   0.1250          -1.1675             0.0033                 
  BTEB transcription factor                                     *Pimephales promelas*      [ABO28528](ABO28528)           107     1.00E-21   0.0625          -1.2019             0.0625                 \*
  myosin regulatory light chain 2                               *Salmo salar*              [CAD89610](CAD89610)           330     7.00E-89   0.1250          -1.2121             0.0020                 
  similar to Clca1 protein                                      *Danio rerio*              [XP_694323](XP_694323)         198     2.00E-49   0.0625          -1.2547             0.0625                 \*
  ependymin                                                     *Perca flavescens*         [ABU49423](ABU49423)           168     2.00E-40   0.0625          -1.2602             0.0625                 \*
  **aspartoacylase**                                            *Danio rerio*              [NP_001103573](NP_001103573)   384     e-105      0.0625          -1.3905             0.0625                 \*
  [Immune]{.ul}                                                                                                                                                                                         
  carboxypeptidase B                                            *Paralichthys olivaceus*   [BAC53789](BAC53789)           365     2.00E-99   0.1250          1.2897              0.0041                 
  fish-egg lectin (FEL)                                         *Cyprinus carpio*          [P68512](P68512)               192     2.00E-47   0.1250          1.1769              0.0003                 
  procathepsin B                                                *Oncorhynchus mykiss*      [AAK69705](AAK69705)           346     1.00E-93   0.0625          -1.1727             0.0625                 \*
  gamma-glutamyl hydrolase                                      *Danio rerio*              [NP_998487](NP_998487)         223     6.00E-57   0.0625          -1.1939             0.0625                 \*
  membrane glycoprotein                                         *Human coronavirus*        [ABD75532](ABD75532)           53      1.00E-05   0.0625          -1.1945             0.0625                 \*
  **beta-2 microglobulin**                                      *Salmo salar*              [AAG17525](AAG17525)           176     8.00E-43   0.1250          -1.1995             0.0034                 
  microtubule-associated protein 1 light chain 3 alpha          *Danio rerio*              [NP_999904](NP_999904)         238     3.00E-61   0.0625          -1.2245             0.0625                 \*
  microtubule-associated protein, RP/EB family, member          *Danio rerio*              [NP_998805](NP_998805)         272     1.00E-71   0.0625          -1.2298             0.0625                 \*
  T-cell receptor beta chain ANA 11, putative                   *Brugia malayi*            [EDP38115](EDP38115)           63      2.00E-08   0.1250          -1.2600             0.0052                 
  glycerophosphodiester phosphodiesterase domain containing 1   *Danio rerio*              [NP_001004118](NP_001004118)   322     2E-86      0.0625          -1.2652             0.0625                 \*
  CHK1 checkpoint homolog                                       *Xenopus tropicalis*       [CAJ83813](CAJ83813)           92      2.00E-17   0.1250          -1.3981             0.0013                 
  [Apoptosis]{.ul}                                                                                                                                                                                      
  tissue inhibitor of metalloproteinase 2                       *Oncorhynchus mykiss*      [AAU14867](AAU14867)           265     3.00E-69   0.1250          1.1235              0.0082                 
  cathepsin H                                                   *Danio rerio*              [NP_997853](NP_997853)         300     5.00E-80   0.1250          1.0898              0.0069                 
  **caspase-3**                                                 *Dicentrarchus labrax*     [ABC70996](ABC70996)           223     6.00E-68   0.1250          -1.0647             0.0022                 
  caspase-1                                                     *Dicentrarchus labrax*     [ABB05054](ABB05054)           79      3.00E-13   0.1250          -1.1270             0.0061                 
  cathepsin S-like                                              *Oncorhynchus mykiss*      [AAV32964](AAV32964)           291     1.00E-77   0.1250          -1.1507             0.0047                 
  [Redox and metal ion binding]{.ul}                                                                                                                                                                    
  hydroxymethylbilane synthase                                  *Danio rerio*              [CAM15096](CAM15096)           369     e-101      0.1250          1.3333              0.0042                 
  **hemopexin**                                                 *Danio rerio*              [NP_001104617](NP_001104617)   313     2.00E-83   0.1250          1.2968              0.0052                 
  transferrin                                                   *Salvelinus fontinalis*    [BAA84100](BAA84100)           326     1.00E-87   0.1250          1.1769              0.0080                 
  similar to leprecan-like 1 protein                            *Danio rerio*              [XP_695073](XP_695073)         183     1.00E-44   0.1250          1.1543              0.0036                 
  similar to synaptic glycoprotein SC2                          *Danio rerio*              [XP_693420](XP_693420)         430     e-119      0.1250          -1.1340             0.0073                 
  similar to LOC407663 protein                                  *Danio rerio*              [XP_698537](XP_698537)         124     6.00E-27   0.0625          -1.2429             0.0625                 \*
  [Growth and development]{.ul}                                                                                                                                                                         
  yghl1 (Putative growth hormone like protein-1)                *Seriola quinqueradiata*   [BAB62526](BAB62526)           153     1.00E-35   0.1250          -1.1388             0.0072                 
  **ZPA domain containing protein**                             *Oryzias latipes*          [NP_001098216](NP_001098216)   168     3.00E-40   0.0625          -1.1568             0.0625                 \*
  [Detoxification]{.ul}                                                                                                                                                                                 
  **pregnane × receptor**                                       *Oncorhynchus mykiss*      [ABP38412](ABP38412)           206     2.00E-51   0.0625          -1.2321             0.0625                 \*
  [Osmotic stress]{.ul}                                                                                                                                                                                 
  hyperosmotic glycine rich protein                             *Salmo salar*              [AAO32675](AAO32675)           134     8.00E-30   0.1250          -1.1053             0.0021                 
  [Digestion]{.ul}                                                                                                                                                                                      
  similar to Apoa4 protein isoform 2 (Apolipoprotein)           *Danio rerio*              [XP_698920](XP_698920)         296     7.00E-79   0.1250          1.4959              0.0056                 
  chymotrypsinogen 2-like protein                               *Sparus aurata*            [AAT45254](AAT45254)           460     e-128      0.1250          1.4211              0.0095                 
  pancreatic carboxypeptidase A1 precursor copy 2               *Tetraodon nigroviridis*   [AAR16321](AAR16321)           242     9.00E-63   0.1250          1.3204              0.0025                 
  pancreatic protein with two somatomedin B domains             *Paralichthys olivaceus*   [BAA88246](BAA88246)           214     e-100      0.1250          1.1297              0.0021                 
  chitinase (Zgc:55941)                                         *Danio rerio*              [AAH44549](AAH44549)           369     e-100      0.1250          -1.0618             0.0097                 

Genes selected for quantitative PCR analyses are shown in bold. \* indicates genes responding at 0.0625 μg.L^-1^esfenvalerate and \*\* indicates gene responding to both 0.0625 and 0.125 μg.L^1^esfenvalerate. Remaining genes responded only at 0.125 μg.L^1^esfenvalerate exposure. Information represents proportions of a limited number of available genes on the applied microarray.

![**Functional classification of gene expression**. Functional classification of genes responding to esfenvalerate exposure (0.0625 and 0.125 μg.L^-1^) in 52-d old delta smelt. Percentages were calculated based on function and biological processes of 94 unique differentially expressed genes.](1471-2164-10-608-2){#F2}

Differences between methods used allow for greater mining of possible biomarkers. The method by Loguinov *et al*\[[@B32]\] identified a single differentially expressed gene at 0.125 μg/L^-1^ esfenvalerate (with no significant homology). The addition of LIMMA GUI analysis, also identifying this single gene, generated a broader list of genes for biomarker selection.

A large percentage of uniquely annotated genes, responding to esfenvalerate exposure; 49%, were classified as involved in various biological processes. These included genes encoding for ribosomal proteins, t-RNA synthases, telomerases, uncoupling proteins and genes involved in chromosome maintenance. Of greater interest was the identification of genes involved in neuromuscular activity; representing 19% of identified sequences, a further 12% eliciting immune responses, along with 6% related to oxidative stress, respiration and iron storage and 5% relevant to apoptosis. Digestion appears to have also been affected, along with growth and development, represented by genes coding for pancreatic enzymes, a zona pellucida protein; inferred to be choriogenin, and a growth hormone.

A selected group of genes, highlighted in bold in the gene list in table [1](#T1){ref-type="table"}, were validated using q-PCR and further investigated for use as molecular biomarkers. These results are described below, in conjunction with differentially expressed genes identified through microarray application.

Specific effects of esfenvalerate exposure on gene expression
-------------------------------------------------------------

Pyrethroid insecticides are known sodium and potassium channel modulators \[[@B25]\], with axon demyelinating effects \[[@B27]\]. This the proof-of-principle microarray assessment of esfenvalerate exposure of 52-d old delta smelt, was successfully used to screen for, and further understand its mode of action, identifying neuromuscular responses, that were confirmed as highly significant through qPCR, corroborating known effects of this pesticide, but also pointing at other significant effects upon growth and development, digestion and the immune system. Gene expression assessed by qPCR on 10-d old delta smelt that verified these genomic responses are presented below. Correlations in expression between q-PCR investigated genes are shown in table [2](#T2){ref-type="table"} and fold changes in gene expression are summarized in figure [3](#F3){ref-type="fig"} and table [3](#T3){ref-type="table"}.

###### 

Pairwise correlations of gene expression in esfenvalerate exposed 10-d old delta smelt.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Aspartoacylase   Titin a             Microglobulin       Caspase-3           Parvalbumin         Hemopexin           ZPA                 Myozenin        Creatine Kinase   PXR
  ----------------- ---------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- --------------- ----------------- -----
  Aspartoacylase    1\                                                                                                                                                                         
                    (0)                                                                                                                                                                        

  Titin a           0.490 (0.402)    1\                                                                                                                                                        
                                     (0)                                                                                                                                                       

  Microglobulin     0.576 (0.310)    0.954 (**0.012**)   1\                                                                                                                                    
                                                         (0)                                                                                                                                   

  Caspase-3         0.344 (0.571)    0.919 (**0.027**)   0.921 (**0.026**)   1\                                                                                                                
                                                                             (0)                                                                                                               

  Parvalbumin       0.284 (0.644)    0.953 (**0.012**)   0.928 (**0.023**)   0.981 (**0.003**)   1\                                                                                            
                                                                                                 (0)                                                                                           

  Hemopexin         0.629 (0.256)    0.819 (0.090)       0.951 (0.013)       0.860 (0.061)       0.822 (0.088)       1\                                                                        
                                                                                                                     (0)                                                                       

  ZPA               -0.017 (0.979)   0.788 (0.113)       0.646 (0.239)       0.853 (0.066)       0.871 (0.054)       0.472 (0.422)       1\                                                    
                                                                                                                                         (0)                                                   

  Myozenin          0.309 (0.613)    0.898 (**0.038**)   0.949 (**0.014**)   0.909 (**0.033**)   0.943 (**0.016**)   0.892 (**0.042**)   0.677 (0.210)       1\                                
                                                                                                                                                             (0)                               

  Creatine Kinase   0.255 (0.679)    0.916 (**0.029**)   0.865 (0.058)       0.984 (**0.003**)   0.978 (**0.004**)   0.759 (0.137)       0.932 (**0.021**)   0.859 (0.062)   1\                
                                                                                                                                                                             (0)               

  PXR               0.880\           0.087\              0.208\              -0.113\             -0.153\             0.307\              -0.475\             -0.038\         -0.218\           1\
                    **(0.049)**      (0.890)             (0.737)             (0.857)             (0.805)             (0.616)             (0.418)             (0.952)         (0.725)           (0)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Numbers represent correlation coefficients; r, and significance probabilities; (p), between ten selected biomarkers assessed with quantitative PCR. Bold p-values highlight significant correlations.

###### 

Mean and standard deviations in fold changes in gene expression of ten selected biomarkers in esfenvalerate exposed, 10-d old, delta smelt, assessed by quantitative PCR.

  Gene\\Concentration          0.000     0.031     0.063     0.125     0.250
  --------------------- ------ --------- --------- --------- --------- ---------
  Aspartoacylase        Mean   1.000     0.629     0.346     0.299     0.244
                        *SE*   *0.240*   *0.100*   *0.078*   *0.035*   *0.088*
  Titin                 Mean   1.000     1.515     0.909     0.933     0.475
                        *SE*   *0.529*   *0.198*   *0.095*   *0.192*   *0.096*
  Microglobulin         Mean   1.000     1.420     0.760     0.828     0.628
                        *SE*   *0.404*   *0.127*   *0.104*   *0.154*   *0.221*
  Caspase               Mean   1.000     2.024     1.136     0.818     0.670
                        *SE*   *0.336*   *0.432*   *0.043*   *0.117*   *0.094*
  Parvalbumin           Mean   1.000     1.718     1.097     1.037     0.771
                        *SE*   *0.241*   *0.151*   *0.125*   *0.062*   *0.107*
  Hemopexin             Mean   1.000     1.501     0.521     0.548     0.612
                        *SE*   *0.089*   *0.296*   *0.051*   *0.147*   *0.295*
  ZPA                   Mean   1.000     1.612     1.455     1.165     0.912
                        *SE*   *0.415*   *0.321*   *0.224*   *0.210*   *0.574*
  Myozenin              Mean   1.000     1.730     0.857     1.069     0.835
                        *SE*   *0.212*   *0.205*   *0.121*   *0.093*   *0.188*
  Creatine Kinase       Mean   1.000     1.799     1.265     0.968     0.750
                        *SE*   *0.270*   *0.249*   *0.272*   *0.162*   *0.145*
  PXR                   Mean   1.000     0.737     0.668     0.737     0.729
                        *SE*   *0.126*   *0.083*   *0.124*   *0.080*   *0.178*

![**Molecular biomarkers responses**. Fold changes in gene expression of ten selected biomarkers in esfenvalerate exposed, 10-d old, delta smelt, assessed by quantitative PCR. Significance in expression differences, as determined by One-way ANOVA, is shown in brackets in legend.](1471-2164-10-608-3){#F3}

### i. Neuromuscular responses

Parvalbumin expression in 10 d old larvae was induced 1.8-fold (t-test, p = 0.008) at 0.0313 μg.L^-1^esfenvalerate, reducing in expression at higher concentrations. Localized in fast-contracting muscles, some endocrine tissues, in the nervous system in GABAergic interneurons and in the brain \[[@B33]\], parvalbumin removes calcium from myofibrils, protecting neurons from hyper-excitability and facilitating muscle relaxation \[[@B34]\]. Accumulation of calcium in muscular tissue contributes to muscle degradation, muscular dystrophy and muscle fiber necrosis \[[@B35]\]. Estrogen is required for parvalbumin expression, thus estrogen receptor-β co-expresses with parvalbumin \[[@B36]\]. Estrogen is also required in brain development and has a protective neurological role, by regulating the activity of GABAergic systems within the hippocampus, basal forebrain and hypothalamus \[[@B37]\]. Differential expression of parvalbumin on exposure to esfenvalerate may be resultant of estrogenic effects. Pyrethroid pesticides have steroid receptor-binding activity \[[@B38]\] linked with endocrine disruption \[[@B39]\], thus exposure is likely to affect the population dynamics of wildlife not only through neuromuscular impairments, but also by affecting reproductive output \[[@B29],[@B40]\]. Parvalbumin, could therefore, be a good indicator of possible endocrine-disruption as well as neuromuscular impairments.

Interestingly, expression of aspartoacylase (ASPA) in exposed 10-d old delta smelt larvae was significantly affected at all concentrations, downregulating with increasing esfenvalerate concentration in a dose response manner, and correlating significantly with swimming anomaly at 24 h (r = 0.913, p = 0.029). Aspartoacylase catalyzes hydrolysis of *N*-acetyl-L-aspartate (NAA) to aspartate and acetate in the vertebrate brain \[[@B41]\]. Variations in NAA measured in urine, blood and brain, have been used as diagnosis of nervous system diseases such as Alzheimer\'s and multiple sclerosis \[[@B42],[@B43]\]. Measurements of NAA, along with ADP levels determined by creatine kinase activity, are used to evaluate the energetic state of the brain, a positive linear correlation existing between NAA and ADP synthesis \[[@B44]\]. Deficiency in ASPA activity leads to degeneration of the myelin; an ensheathment that isolates and controls axonal activity, it is associated with schizophrenia \[[@B45]\], and is the established cause of leukodystrophy in Canavan\'s disease \[[@B43]\]. Abnormal myelination is known to result from acyltransferase deficiency \[[@B46]\]. Ependymin, a myelin associated glycoprotein related to memory formation and involved in neuronal regeneration \[[@B47]\], was also negatively affected by esfenvalerate. Myelin has been postulated as a probable modulator of ASPA activity \[[@B48]\] further affecting this critical pathway of neurological function. ASPA protein activity is a strong biomarker of brain damage and neurological impairment investigation, used regularly in human and veterinary disease diagnostics \[[@B49]\].

Creatine kinase was significantly up-regulated at 0.0313 μg.L^-1^esfenvalerate (t-test, p \< 0.05). Creatine kinase protein is used not only as a diagnosis of brain energetic value as mentioned above, but also of diseases like cardiac infarction and skeletal muscle necrosis \[[@B50]\]. In muscle, creatine kinase is specifically bound to sarcoendoplasmic reticulum, and regulates calcium uptake and ATP/ADP ratios \[[@B51]\], thus is directly involved in muscle contraction. Of interest here, are the pathway links and correlating responses (r = 0.98) between parvalbumin; facilitating muscle relaxation by binding calcium, and creatine kinase, which regulates calcium uptake. These two parameters on their own indicate muscular activity impairments, creating strong links with observed larval swimming behavior.

Titin expression also correlated significantly with parvalbumin (r = 0.95) and creatine kinase (r = 0.92), though not statistically significant in q-PCR assessments of 10-d old smelt larvae. Titin is an important protein also involved in muscle contraction, responsible for muscle elasticity and is the molecular scaffold for thick actin filament formation, forming a connection between filaments and the muscle Z-line \[[@B52]\]. Myozenin, another protein involved in muscle contraction, was significantly influenced by esfenvalerate exposure (t-test, p \< 0.05) in 10-d old larvae. Co-regulating with Titin (r = 0.90), myozenin is a Z-line, α-actinin- and γ-filamin-binding protein expressed predominantly in skeletal muscle, and has been suggested as a biomarker for muscular dystrophy and other neuromuscular disorders \[[@B53]\].

### ii Immune responses

In this study we have identified a significant alteration in expression of several genes involved in immune responses, most of them with links to neurological damage. β-microglobulin, a small protein normally found on the surface of many cells, including lymphocytes, is known to be involved in cell protection \[[@B54]\]. β-microglobulin is almost exclusively catabolized in the kidney and its excretion is an indication of long term nephrotoxicity \[[@B55]\]. High concentrations of β-microglobulin are reported to inhibit generation of functional dendritic cells \[[@B56]\], thus an increased amount in the blood or urine may be a sign of neural degeneration and of certain diseases, including some types of cancer, such as multiple myeloma or lymphoma. β-microglobulin levels are also reported to rise following viral infection and its reduced expression can compromise the immune system \[[@B57]\]. Interestingly, exposure to esfenvalerate resulted in a significant increase of pathogen susceptibility in chinook salmon \[[@B9]\]. β-microglobulin assessment with q-PCR did not show any significance in expression in 10 d old larvae (t-test, p = 0.131), however, an overall increase was observed at low concentrations of esfenvalerate, correlating significantly with expression of other genes investigated, further discussed below.

Multiple sclerosis is caused by an immunological attack on myelin \[[@B58]\], decreasing NAA and resulting in neurological instability. Furthermore, oxidative stress is inductive of apoptosis of myelin-reactive T cells \[[@B59]\]. A putative T cell receptor gene was identified through microarray screening, probably reacting to pyrethroid exposure, acting upon the myelin sheath and causing further neurological damage and cell death.

### iii Apoptotic responses

Caspases (*c*ysteine-*asp*artic acid prote*ase*) belong to a family of cysteine proteases that cleave other proteins, such as the precursor forms of the inflammatory cytokines interleukin 1-β and interleukin 18, into active mature peptides and are also involved in programmed cell death; or apoptosis \[[@B60]\]. Enzymatic activity requires an aspartic acid residue, and plays a critical role in the regulation of proinflammatory cytokines \[[@B61]\] that are associated with septic shock and autoimmune syndromes \[[@B62]\]. Upregulation of proinflammatory cytokines were reported in viral infected salmon, which further increased in expression following esfenvalerate exposure \[[@B63]\]. Caspases contribute to the pathogenesis of neurodegenerative disorders such as ischemia, Krabbes and Huntington\'s diseases, Alzheimer\'s, and other leukodystrophic diseases resulting in neural degeneration \[[@B64],[@B65]\]. Moreover, caspase inhibitors have been suggested as therapeutic treatments for neurodegenerative diseases \[[@B66]\]. Low concentrations of esfenvalerate; 0.0313 μg.L^-1^, significantly induced caspase-3 expression 2-fold (t-test, p = 0.002) in 10-d old delta smelt. As caspases are activated by aspartic acid, induction may be suggestive of increases in substrate residues, along with inflammatory cytokines, probable effects upon the immune system, and subsequent neurodegeneration. Furthermore, a decrease in ASPA expression could be suggestive of reduced breakdown of NNA to aspartate and acetate, required as substrate for caspase activity, and synthesis of proteins required in repair mechanisms.

### iv. Redox and metal ion binding

Upregulation of hemopexin was confirmed by quantitative PCR in 10-d old delta smelt exposed to 0.0313 μg.L^-1^esfenvalerate. Hemopexin-like protein, a gene sequence displaying vast similarities to warm-temperature-acclimation-related-65 protein (WAP65) on BLAST homologies with Japanese medaka (*Oryzias latipes*), was identified as significantly upregulated through microarray screening. Hemopexin is synthesized by Schwann cells following nerve injury \[[@B67]\], accumulation has been reported in the peripheral nervous system following axonal lesions, and is specifically regulated during repair, returning to normal levels on axonal regeneration \[[@B68]\]. Wallerian degeneration occurs after axonal injury and is critical for repair, it is characterized by axonal and myelin degeneration \[[@B69]\], is accompanied by macrophage invasion and subsequent synthesis of hemopexin \[[@B67]\]. Hemopexin appears to play a significant role in neural regeneration, but may be resultant of oxidative stress mediated T cell activity on myelin sheaths (described above, under immune responses). Though upregulation follows nerve injury and there are strong connections with apoptosis, we classify hemopexin under oxidative stress as it has a high affinity with heme and reportedly plays a strong role in both heme transport and preventing heme-catalyzed oxidative damage \[[@B70]\]. Moreover, pyrethroids have been shown to generate free radicals and induce oxidative stress \[[@B71]\]. Heme is known to respond to nerve injury, and has been suggested to play a role in neurodegenerative disorders \[[@B72]\], and hemopexin-mediated heme transport was reported to significantly decrease levels of transferrin receptor mRNA in HeLa cells \[[@B70]\]. Transferrin was also identified by microarray screening as significantly upregulated by esfenvalerate exposure. The primary role of transferrin is the delivery of iron across the blood brain barrier, and its expression in brain is not only related to myelin production, but may be a permissive agent in the process of myelination \[[@B73]\]. Furthermore, hemopexin and transferrin reportedly act by similar receptor-mediated mechanisms \[[@B74]\].

### v. Growth and development

Microarray analyses identified a gene with high homology to egg envelope glycoproteins within the zona pellucida (ZPA) referred to as choriogenins, in fish \[[@B75]\]. This was significantly expressed in 52-d old larvae, however, no statistical differences in expression of ZPA were measured with qPCR in 10-d old larvae exposed to esfenvalerate. Choriogenin is reportedly more sensitive to endocrine disrupting chemicals (EDCs) than estrogen receptors and vitellogenin \[[@B76]\]. Composed primarily of glycoproteins with various functions during fertilization and development, choriogenin has been suggested as a biomarker of exposure to endocrine disrupting chemicals, as it is induced in late stage embryos, larvae and adult male fish exposed to estrogens \[[@B76],[@B77]\]. Choriogenin is synthesized in liver of adult females, in response to estrogen, transported in blood and incorporated into the fish egg envelope; chorion or zona pellucida (ZPA), an extracellular matrix that surrounds the oocyte and early embryo \[[@B78]\]. Expression was notably elevated at low pyrethroid concentration, and it responded in a similar fashion to creatine kinase (r = 0.93), though no significant links were identified between these two biomarkers.

### vi. Detoxification

Pregnane × receptor (PXR), involved in the detection of toxic substances and a key regulator of xenobiotic metabolism, was identified through microarray assessments, as downregulated in 52-d old larvae. PXR is a steroid receptor and transcriptional regulator of detoxification mechanisms such as cytochrome oxidases, and phase II conjugating enzymes such as glutathione-*S*-tranferases \[[@B79],[@B80]\]. Downregulation of PXR expression has been linked with growth inhibition and cell death in rats and human cell lines following exposure to medroxyprogesterone and estradiol, known PXR ligands \[[@B80]\], further supporting identified apoptotic responses, steroid receptor-binding and endocrine disruption activity of esfenvalerate \[[@B38],[@B39]\]. PXR expression was not significantly different in q-PCR assessments of 10-d old larvae exposed to esfenvalerate, however, overall expression declined in a dose response manner, correlating with ASPA (r = 0.880; p = 0.049), making it a notable candidate of xenobiotic detection for future biomarker investigations in the delta smelt.

### vii Osmotic Stress

A hyperosmotic glycine rich protein was identified with the microarrays as significantly downregulated by exposure to 0.0625 μg.L^-1^esfenvalerate in 52-d old larvae. Osmoregulation is physiologically controlled by chemical messages from the endocrine system, along with cell signalling and nerve transmission \[[@B81]\]. Pyrethroids have been suggested to induce osmotic imbalances in common carp larvae \[[@B82]\] which are linked to effects on ATPase activity responsible for maintaining the Sodium trans-membrane electrochemical gradient \[[@B83]\]. Larval fish are under direct exposure to osmotic stress as their endocrine system is not fully developed \[[@B84]\]. Parvalbumin and choriogenin expression have indicated possible effects on the endocrine system, thus expression of this hyperosmotic glycine rich protein may be directly caused by conditions affecting endocrine regulation.

### viii Digestion

Chitinase was identified through microarray analysis as being downregulated by esfenvalerate exposure. Chitinase is the principal enzyme involved in digesting chitin, a major component of insect and crustacean exoskeleton \[[@B85]\]. Larval smelt were fed on artemia during the pre-exposure acclimation period. Not only chitinase but, other digestive enzymes; apolipoproteins, pancreatic enzymes, carboxypeptidase precursors and chemotrypsinogen, were also significantly upregulated following exposure in 52-d old larvae. Effects on digestion alone will undoubtedly have significant effects on growth, which when combined with hypothesized feeding reduction resulting from impaired swimming would lead to significant malnutrition. Contaminants affect a whole ecosystem, at all levels, and dramatic reductions in copepods, cladoceran and amphipod populations; organisms predated upon by the delta smelt, have been reported in the Sacramento delta \[[@B86]\]. Scarcity in food and reduced ingestion ability, besides digestion will significantly affect population dynamics of any specie.

Conclusions
===========

Microarray technology was used as an initial screening of probable genes responding to esfenvalerate exposure therefore no multiple testing correction was applied. We have, however, examined and confirmed effect of esfenvalerate upon some of the genes in a different age group of larval delta smelt, identifying significant responses that are primarily linked with swimming behavior. Some responding genes can be classified within different functional groups. Due to the measured behavioral responses, the classification approach contains a certain bias towards understanding neuromuscular effects. It is interesting that qPCR measurements have identified a greater response at the lower concentrations, implying homeostatic alterations, at environmentally relevant concentrations. Most genes did not display a desired dose response correlation associated with usable biomarkers, but did support responses within the suite of genes investigated, somewhat validating their use within a broader biomarker approach. Hemopexin for example is known to be involved in axon repair, and the myelin sheath surrounding the axon needs to be degraded for this repair to be processed, hypothesizing therefore that ASPA downregulation is resultant of neurological damage. The subsequent decrease of hemopexin expression at higher exposure concentrations, and further decrease in ASPA, may be indicative of repair impairments.

What becomes apparent from this study is that exposure to sublethal concentrations of esfenvalerate results in neurological damage and a series of compensatory molecular responses that attempt to repair nerve damage. We would hypothesize that induction of transcription of the genes encoding ASPA, hemopexin, parvalbumin and creatine kinase are part of a pathway of damage triggered repair mechanisms, responding to esfenvalerate insult. Reduction in expression of ASPA indicates that myelin sheaths may be degraded, resulting in a number of detrimental effects on the lesion sites, and similarly, muscular structure and function is being compromised as measured by alterations in titin and myozenin expression. The expression of β-microglobulins could be a compensatory reaction to toxic damage, protecting cells from infections in a susceptible immune system caused by exposure to esfenvalerate. Previous studies, carried out in esfenvalerate exposed chinook salmon have reported a compromised immunity and significantly higher susceptibility to infection \[[@B9],[@B63]\]. This is particularly important in younger organisms that are generally more susceptible than adults. Furthermore, polluted waters not only contain mixtures of contaminants, but also harbor multiple pathogens that will further affect health parameters.

Behavioral endpoints, such as swimming behavior, are amongst the most sensitive and ecologically relevant parameters to assess sublethal toxicity of neurotoxic chemicals \[[@B29]\]. The high susceptibility of delta smelt to esfenvalerate, mediated neurological damage resulting in impaired swimming ability, also raises questions on the likely effects upon their chemosensory system; olfactory system, important in sensing reproductive pheromones, mediating reproduction. Females synthesize sex hormones stimulating male reproductive behavior \[[@B87]\]. Neurological damage affecting the olfactory nerves, the brain and or entire nervous system, could lead to further impairments in reproductive success following exposure to pyrethroids. Damage to the olfactory system has been used as a sublethal toxicological endpoint in fish, in studies investigating behavior following pesticide exposures \[[@B88]\]. Pyrethroids are known to affect the olfactory system \[[@B89]\]. A chemosensory gene, ictacalcin, responding to esfenvalerate exposure was also differentially expressed on the microarray. Ictacalcin is a gene originally identified in catfish (*Ictalurus punctatus*), involved in chemosensory tissues, and highly expressed in barbell, olfactory mucosa and gill \[[@B90]\]. Differential expression of this gene may indicate that further behavioral parameters, not investigated in this study, such as recognition, alarm response, feeding, imprinting and homing, gamete release and synchronization, contaminant avoidance \[[@B88]\], and other behavioral parameters that are governed by chemosensory system, could be compromised. We could speculate that outside laboratory conditions, neuromuscular and chemosensory impairments would probably result in higher ecological parameters being affected through inability to swim against water currents, making them more susceptible to predation and reducing their ability to obtain food. Furthermore, effects on chemosensory parameters would lead to migratory, reproductive, predator and contaminant avoidance impairments.

Inhibition of repair mechanisms, leading to neuromuscular damage and eventual death, was behaviorally observed throughout exposure, as impairment in swimming ability. The ability to use molecular biomarkers of neuromuscular effect further strengthens links between mechanistic effects with parameters of ecological relevance. Our study supports the use of gene expression as a productive way of understanding modes of actions of individual chemicals in endangered species. Furthermore, this screening and interrogative approach permits the identification and development of biomarkers for species of concern in which prior information is limited and allows for investigations into problems specific to the organism in question; assessing possible causes of detrimental effects and resulting influences on individual performance and hypothesizing effects upon population dynamics. A suite of biomarkers developed in this manner, though additions and subtractions are required from the presented list, could be used to aid monitor impacts of stressors upon organisms within a specific environment and could be an essential tool in determining causative factors of population decline in the delta smelt and other threatened species. The selected biomarkers clearly need to be further investigated and validated against other known contaminants, and suitability in field applications.

Methods
=======

Microarray construction
-----------------------

We constructed a delta smelt microarray using 8448 PCR amplified fragments from a normalized cDNA library. A cDNA library was created using expressed sequence tags (ESTs) ligated into *p-BS*plasmid vectors and cloned into chemically competent *Escherichia coli*cells (BioS&T Inc, Montreal, Quebec, Canada). RNA for library construction was obtained from a number of larval, juvenile and adult delta smelt, ranging from unexposed, control conditions, to fish from exposures to high temperature (25°C), and sublethal concentrations of copper, esfenvalerate, and a six field water samples from throughout the Sacramento-San Joaquin estuary. Products were PCR amplified from 1 μl bacterial suspension, and visualized on agarose gels. Purified PCR fragments ranging in size from 1-4 kb, along with control spots, were pin-printed in duplicate onto epoxysilane coated glass slides (Schott-Nexterion, USA) in a 20 × 19 block format, with 48 blocks per microarray. Microarrays were printed using a Lucidea Array Spotter (Amersham) at the Array Core facility at UC Davis (since closed down). Microarray control spots included a number of hybridization tags comprised of a pooled PCR product from all spots on the array, *H. transpacificus*DNA, and four Spot Report System of alien PCR products from *Arabidopsis thaliana*; *CAB*, *RCA*, *RBCL*and *LPT4*(Stratagene, USA). Blank control spots consisted of 1× Nexterion buffer solution.

Esfenvalerate exposures
-----------------------

Delta smelt larvae aged 10 d and 52 d were exposed for 24 h, in two separate experiments, to a range of esfenvalerate concentrations; 0.0313, 0.0625, 0.125, 0.250 and 0.500 μg.L^-1^(nominal) in laboratory control water, with corresponding laboratory and solvent controls. Concentrations were measured at the start of the experiment by the Water Pollution Control Laboratory at the Department of Fish and Game (Rancho Cordova, California, USA), only single measurements were taken per treatment (results not shown), therefore we present the data in terms of nominal concentrations. Laboratory control water consisted of deionized water amended to US EPA moderately hard standards (80-100 mg.L^-1^CaCO~3~) and 200 μl/L methanol was used as solvent carrier. Salinity was adjusted with Instant Ocean salt to match hatchery rearing conditions (range 650 μS.cm^-1^to 900 μS.cm^-1^).

Average wet weights of 10-d to 52-d old larval delta smelt ranged from 0.5 to 2.5 mg respectively. Larvae were obtained from the Fish Conservation and Culture Laboratory (FCCL) UC Davis, Byron, CA, transported in cool, oxygenated 2-gallon black buckets, and held overnight in the laboratory at 17°C and a 8 h:16 h D:L light cycle. The following day, ten larvae were transferred to each 2-L beaker containing 1 L of aerated control water or esfenvalerate treatment. Each treatment consisted of 4 replicates and tests were performed at 8 h:16 h D:L cycle, at a water temperature of 17°C ± 1.2°C. The pH during the tests was 7.1 - 7.5. Dissolved oxygen levels were within the acceptable range for delta smelt (above 6.5 mg.L^-1^)\[[@B91]\]. Larvae were fed rotifers the day before the test start, but not during the 24 h exposure. Rotifer cultures were obtained from FCCL. During exposure, larvae were observed for aberrant swimming behavior, and surviving fish were scored after 4 h and 24 h. Swimming behavior was assessed by observing each tank for 5 min as described in Geist *et. al*. \[[@B17]\]. Any pronounced deviation (\> 1 min) from normal (control) swimming patterns were recorded as abnormal. Effects on swimming performance (EC~50~) and mortality (LC~50~) were assessed using linear regression analysis with Environmental Toxicity Information System (CETIS) by Tidepool Scientific Software (McKinleyville, CA, USA).

Four surviving 52 d old larvae from solvent controls, and exposures to 0.0625 and 0.125 μg.L^-1^esfenvalerate, were used for microarray analyses, hybridized in a reference design against a pool of RNA from all treatments. Four replicate 10 d old larvae from each treatment (controls and 0.0312, 0.0625, 0.125 μg.L^-1^esfenvalerate) were used for biomarker analyses and gene expression verification using quantitative PCR (q-PCR).

All experiments and use of test organisms were approved by the UC Davis Institutional Animal Care and Use Committee (Animal Use Protocol for Animal Care and Use \#13361). This institution is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC) and has an Animal Welfare Assurance on file with the Office of Laboratory Animal Welfare (OLAW). The Assurance Number is A3433-01. The IACUC is constituted in accordance with U.S. Public Health Service (PHS) Animal Welfare Policy and includes a member of the public and a non-scientist.

RNA isolation, cDNA synthesis and fluorescence labeling
-------------------------------------------------------

RNA was extracted from whole, individual organisms using a standard phenol:chloroform protocol with Trizol Reagent (Invitrogen). Fifteen micrograms of total RNA were used for cDNA synthesis, spiked with control RNA (CAB, RCA, RBCL and LTP4 (SpotReport, Stratagene) and labeled with Alexa fluor dyes, using SuperScript™ Plus Indirect cDNA labeling System (Invitrogen). Each experimental sample and control was combined with a reference pool cDNA prior to hybridization using an automated Tecan HS4800 hybridization station. Slides were scanned using a GenePix 4000B scanner (Axon Instruments).

Microarray images and data from esfenvalerate exposed delta smelt can be accessed at <http://www.vetmed.ucdavis.edu/apc/WernerLab/subpage/pelagic_organism_decline.html>; POD archive data.

Microarray Analyses
-------------------

Normalization and analytical methods are described in Loguinov *et. al*. \[[@B32]\] and Smyth \[[@B92]\]. In brief, print tip normalization was carried out within slides and sequential single slide data analysis was carried out as an alternative to between-slide normalization. An α-outlier-generating model was used to identify differentially expressed genes by applying the following decision rule for multiple-slide data analysis: a given gene was selected as a candidate if it was detected as significantly up- or downregulated in 4 of 4 replicates (raw p-value = 0.0625 using exact binomial test and considering outcomes as Bernoulli trials). The approach did not use scale estimator for statistical inference and, therefore, it did not require between-slide normalization. This method however, detected only one significant differentially expressed candidate gene at the highest exposure concentration (0.125 μg/L^-1^), (with no significant annotation identity - see results and discussion). As a result, a second analytical method was applied to increase the number of probable genes for consideration in biomarker development. Thus we further analyzed the data using LIMMA GUI (Linear model for microarray analysis graphical user interface) \[[@B92]\], written in the R-programming language available through Bioconductor <http://www.Bioconductor.org>. Data was normalized within arrays using print-tip Lowess and between arrays applying aquantile normalization methods \[[@B92]\]. A linear model fit was computed using the duplicates on the arrays and the least-squares method, no multiple assessment methods were applied to eliminate false positives as our aim was to increase the number of genes available for biomarker assessment, and qualify these through quantitative PCR.

Sequencing and Annotation
-------------------------

Sequencing was carried out at the CA&ES Genomic Facility, UC Davis. Basic Local Alignment Search Tool; translated nucleotide (BLASTx) searches were performed on specific fragments that responded significantly to the exposure treatments. Only genes that were differentially expressed following esfenvalerate exposure were sequenced. Sequences were annotated according to homologies to protein database searches using translated nucleotide sequences and direct nucleotide queries <http://blast.ncbi.nlm.nih.gov/Blast.cgi>. Sequences were only annotated if they were found to have a BLASTx match with the expect value smaller than 1 × 10^-5^and a score above 50.

Functional Classifications
--------------------------

Differentially expressed genes were classified according to gene ontology <http://www.uniprot.org/uniprot>, and information gathered from literature, into functional groups. Classification was carried out based on gene expression changes in respect of control subjects, regardless of whether these were up or downregulated, or exposure concentrations. Specific genes of interest were selected for further investigation using quantitative PCR.

Biomarker development
---------------------

Genes were selected according to level of expression significance, knowledge base from literature, and functional classification. Primer and probes for qPCR analyses were designed using Roche Universal Probe Library Assay Design Center <https://www.roche-applied-science.com>. Designed primers were obtained from Eurofins MWG Operon <http://www.eurofinsdna.com>, and TaqMan probes were supplied by Roche. Sequences for all genes assessed by qPCR analyses have been submitted to genbank <http://www.ncbi.nlm.nih.gov>. Primers and probes, and genbank accession numbers, for investigated biomarkers are detailed in table [4](#T4){ref-type="table"}. Myozenin and creatine kinase, though not resulting from the current study, were genes identified in investigations carried out during microarray development, and added to the selected biomarkers due to our interest in neuromuscular activity.

###### 

Primers and probes used for molecular biomarkers: Primer pairs and TaqMan probes used in q-PCR assessments.

  Accession no.          Gene                         Primer Sequences              Probe No.
  ---------------------- ------------------- -------- ----------------------------- -----------
  [FJ711577](FJ711577)   Aspartoacylase      Left:    ggaggcacacatgggaatg           109
                                             Right:   cttcctctgaatctctgttccattatc   
  [FJ711576](FJ711576)   Parvalbumin         Left:    gaccaagacaagagtggcttca        101
                                             Right:   tctggcaccagcagagaagtt         
  [FJ711580](FJ711580)   β-2 microglobulin   Left:    tctttcgcggtcatctttctc         22
                                             Right:   ggttgtggccatacacctgaa         
  [FJ711579](FJ711579)   Hemopexin           Left:    catgcactacgaggacgacaag        143
                                             Right:   tggtagtagctgaacaccttgctg      
  [FJ711578](FJ711578)   Caspase-3           Left:    gagaaccggtatgaaccaacg         159
                                             Right:   tccaagcttcccaaacactttc        
  [FJ711575](FJ711575)   Titin a             Left:    tgatcactggcgtgaaagagg         159
                                             Right:   caagctcattggacagtttgagg       
  [FJ711581](FJ711581)   ZPA                 Left:    catgcggctgagtttggataa         106
                                             Right:   tgccattgatagcatcaacttca       
  [FJ711583](FJ711583)   Myozenin\*          Left:    ccaatgtcgtgctggtacacc         106
                                             Right:   ctgccagacattgatgtagcca        
  [FJ711584](FJ711584)   Creatine kinase\*   Left:    cgatcggcgttggagatg            163
                                             Right:   gccaagttcaacgagattctgg        
  [FJ711582](FJ711582)   PXR                 Left:    tgaggcggtggagaagag            144
                                             Right:   gaggcggtggagaagag             

\* indicates biomarkers obtained from preliminary studies carried out during microarray development.

Quantitative PCR
----------------

A total of 1.5 μg RNA was cDNA synthesized using random primers, and diluted to a total of 50 μl with nuclease free water to generate sufficient template for qPCR analysis. TaqMan Universal PCR Mastermix (Applied Biosystems) was used in q-PCR amplifications in a reaction containing 10mMTris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl2, 2.5 mM deoxynucleotide triphosphates, 0.625 U AmpliTaq Gold DNA polymerase per reaction, 0.25 U AmpErase UNG per reaction and 5 μL of cDNA sample in a final volume of 12 μL. The samples were placed in 384 well plates and cDNA was amplified in an automated fluorometer (ABI PRISM 7900 Sequence Detection System, Applied Biosystems). Amplification conditions were 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C and 60 s at 60°C. Fluorescence of samples was measured every 7 s and signals were considered positive if fluorescence intensity exceeded 10 times the standard deviation of the baseline fluorescence (threshold cycle, *C*T). SDS 2.2.1 software (Applied Biosystems) was used to quantify transcription.

Quantitative PCR data was analyzed using the relative quantification 2(-Delta Delta CT) method ()(\[[@B93]\]. In the absence of house keeping genes, expression was calculated relative to the mean of controls in respective exposures. Surviving larvae from each replicate of the 10-d old exposed delta smelt were used for q-PCR analyses. One-way ANOVA was used to assess differences in gene expression through out the exposure concentrations, and data were further assessed using Student\'s T-test at individual concentrations in respect to solvent controls.
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